📣 ADDS 2027 Registrations Now Open!
We hope you'll join us for our 5th meeting, ADDS 2027, taking place Feb 8-10, 2027 in Atlanta, GA.

Office Closure: Due to Hurricane Isaias, Ametris' offices will be closed Friday, October 9th.
We will reopen at regular business hours on Monday, October 12th.
Posts about

wearables

Ametris and Biosency Partner to Expand Ametris' Respiratory Digital Measures Suite with COPD Exacerbation Endpoints

PENSACOLA, FL, and PARIS, FRANCE, Nov 9, 2026 – Ametris, a Signant Health company and global...

C-Path, ActiGraph, and University of Canberra Collaborate to Generate Evidence to Support Regulatory Qualification of Novel Digital Health Technology Measures in Chronic Heart Failure

Collaboration will generate evidence to contribute to FDA qualification of a patient-centered,...

ActiGraph Launches Collaborative Research Project to Investigate a Nocturnal Scratch Measure for Drug Development

PENSACOLA, FL, November 20, 2023 - ActiGraph, a leader in wearable digital health technology and...

Introducing ActiGraph LEAP: A State-of-the-Art, Multisensor Wearable for Patient-Centered Clinical Research

PENSACOLA, FL, November 13, 2023 - ActiGraph, a leader in wearable digital health technology and...